Real-world retrospective consecutive study of ab interno XEN 45 gel stent implant with mitomycin C in black and afro-latino patients with glaucoma: 40 & #37; required secondary glaucoma surgery at 1 year

CONCLUSIONS: The ab interno XEN gel implant as a standalone procedure or combined with cataract surgery demonstrated a safe and sustained IOP reduction for only 60% of patients after 12 months. In Black and Afro-Latino patients receiving the ab interno XEN implant, 40% of patients needed additional surgery within 12 months.

Source: Middle East African Journal of Ophthalmology - January 28, 2020 Category: Opthalmology Authors: Daniel Laroche Gideon Nkrumah Chester Ng Source Type: research